Insider selling
Traded Apr 4, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
A major shareholder of Impact Biomedical sold $845K of Impact Biomedical shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 20, 2025 · Filed Mar 25, 2025
A major shareholder of Impact Biomedical paid $310 out of pocket for Impact Biomedical shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$310
Shares × reported transaction price
<$25K
+0.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −75.2% | −2.5% | −72.6% |
| 30 days | −87.1% | −5.0% | −82.1% |
| 90 days | −51.2% | +4.3% | −55.5% |
| 180 days | −79.7% | +15.9% | −95.6% |
| 365 days | −82.3% | +14.1% | −96.5% |
Past results only. Not a forecast.
Insider selling
Traded Apr 4, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
A major shareholder of Impact Biomedical sold $845K of Impact Biomedical shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Apr 3, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
An Impact Biomedical director sold $174K of Impact Biomedical shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Apr 2, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
An Impact Biomedical director sold $1.6K of Impact Biomedical shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.